January 28, 2016 – Soft tissue sarcoma (STS) is a disease in which cancer cells form in the soft tissues of the body, including the muscles, tendons, fat, blood vessels, lymph vessels, nerves and tissues around joints. Liposarcoma is a specific …

Eribulin Mesylate (Halaven): First drug to show survival benefit in unresectable or metastatic liposarcoma Read more »

October 24, 2015 –  The Amrican Food and Drug Administration approved Trabectedin (Yondelis) for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who have received a prior anthracycline-containing regimen. The approval of trabectedin is based on improvement in progression-free survival (PFS) in a multicenter, …

Trabectedin (Yondelis) approved by the FDA for unresectable or metastatic liposarcoma or leiomyosarcoma Read more »